Chicago Equity Partners’s Trueblue TBI Stock Holding History

Chicago Equity Partners’s Portfolio TBI Stock Details TBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-36,705	Closed	-$883K	–	856
2019 Q4	$883K	Buy	+36,705	New	+$837K	0.05%	489

Other funds holding TBI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Chicago Equity Partners's TBI Position: Q1 2020 in Review

Chicago Equity Partners sold out of Trueblue (TBI) in Q1 2020, closing a stake of 36,705 shares — an estimated $883K sold.

Chicago Equity Partners first reported a position in TBI in Q4 2019 and held it in 1 quarter. The position peaked at $883K in Q4 2019. 157 funds tracked by Wall St. Rank hold TBI as of Q1 2020.

Chicago Equity Partners reported no remaining Trueblue position as of Q1 2020 after selling out during the quarter.
Chicago Equity Partners sold 36,705 Trueblue shares in Q1 2020, an estimated $883K.
Chicago Equity Partners first reported a position in Trueblue in Q4 2019 and held it in 1 quarter.
Chicago Equity Partners's Trueblue position peaked at $883K in Q4 2019.
157 funds tracked by Wall St. Rank held Trueblue as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.